Clinical Trial Detail

NCT ID NCT02547675
Title Rociletinib (CO-1686) USA Expanded Access Program
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Clovis Oncology, Inc.
Indications

lung non-small cell carcinoma

Therapies

Rociletinib

Age Groups: adult

Additional content available in CKB BOOST